HIGHLIGHTS
- who: James R. Ballinger from the School of Biomedical Engineering and Imaging Sciences, King`s College London, London WC R LS, UK have published the research work: Challenges in Preparation of Albumin Nanoparticle-Based Radiopharmaceuticals, in the Journal: Molecules 2022, 27, 8596. of /2022/
SUMMARY
Copyright: Radiopharmaceuticals are radioactive drugs administered to a patient, generally for diagnostic purposes. The most common radionuclide is the gamma emitter technetium-99m (99m Tc) which has a half-life of 6 h and is obtained from a generator on site. In terms of imaging, 99m Tc sulphide . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.